Trulieve Enters S&P Indices After Delaware Move
Trulieve shares rose 3.1% to $11.86 after being added to S&P Total Market and Completion indices. This move grants access to $95.4 billion in passive funds.
Key points
- Trulieve shares rose 3.1 percent to $11.86 after joining S&P Total Market and Completion indices.
- The addition follows a redomicile to Delaware and a June 10 NYSE listing, meeting S&P eligibility rules.
- Vanguard's Extended Market Index Fund, with $95.4 billion in assets, tracks the index that now includes Trulieve.
Trulieve shares rose 3.1 percent to $11.86 on Tuesday. The price gain followed the company's addition to two major S&P U.S. equity indices. This inclusion marks a significant milestone for the cannabis sector in American markets.
The stock was added to the S&P Total Market Index and the S&P Completion Index. Vanguard's Extended Market Index Fund tracks the latter benchmark. That fund held $95.4 billion in assets as of August 31.
Eligibility driven by Delaware redomicile
S&P indices only include companies domiciled in the United States. Trulieve completed its move from British Columbia to Delaware on August 11. Shareholders approved the redomicile on August 5, clearing the final legal hurdle.
The shares began trading on the New York Stock Exchange on June 10. This listing satisfied the exchange requirement for index inclusion. The company now meets all criteria for U.S. broad market indices.
Trading volume spikes ahead of rebalancing
S&P reconstitutes the Total Market Index after the close of September 18. Trulieve volume reached 12.7 million shares on that specific date. This figure was roughly eight times the average of surrounding sessions.
The high volume likely reflects institutional positioning ahead of the official index change. Passive funds must buy members of the index they track. Trulieve's inclusion ensures these funds will purchase the stock.
Financials support institutional investor interest
Trulieve reported second-quarter revenue of $271 million on August 7. The company achieved a 60 percent gross margin during that period. Adjusted EBITDA came in at $98 million for the quarter.
Cash reserves stood at $325 million at the end of June. The operator runs 207 dispensaries across four U.S. states. It also manages 3.5 million square feet of cultivation space. Mugglehead Investment Magazine notes this scale attracts institutional capital.
